MRNA, is currently undergoing correction phase. To be specific, the prices are forming counterwaves ABC of smaller degree (red labelling of ABC) as part of higher degree of Wave B (black labelling) formation.
It is predicted the higher degree of Wave B will end at around USD163 before making bigger downtrend movement of Wave C. The target for Wave C is to hit minimal of around USD79 (61.8% FIBO correction), or to the worst of around USD49.6 (78.6% FIBO correction).
A stock of potential shorting opportunities on rebound.
Happy trading.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款閱讀更多資訊。